nodes	percent_of_prediction	percent_of_DWPC	metapath
Azathioprine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—skin cancer	0.875	1	CiPCiCtD
Azathioprine—HPRT1—hair follicle—skin cancer	0.00253	0.0707	CbGeAlD
Azathioprine—GSTM1—blood vessel—skin cancer	0.00232	0.0647	CbGeAlD
Azathioprine—HPRT1—nipple—skin cancer	0.00172	0.0479	CbGeAlD
Azathioprine—GSTM1—neck—skin cancer	0.00166	0.0463	CbGeAlD
Azathioprine—GSTA1—connective tissue—skin cancer	0.00161	0.0448	CbGeAlD
Azathioprine—GSTA1—epithelium—skin cancer	0.00152	0.0426	CbGeAlD
Azathioprine—TPMT—nipple—skin cancer	0.00145	0.0404	CbGeAlD
Azathioprine—HPRT1—connective tissue—skin cancer	0.00122	0.034	CbGeAlD
Azathioprine—GSTM1—connective tissue—skin cancer	0.00119	0.0332	CbGeAlD
Azathioprine—GSTA1—lymphoid tissue—skin cancer	0.00117	0.0328	CbGeAlD
Azathioprine—GSTA2—connective tissue—skin cancer	0.00116	0.0324	CbGeAlD
Azathioprine—GSTA1—female reproductive system—skin cancer	0.00113	0.0316	CbGeAlD
Azathioprine—GSTA2—epithelium—skin cancer	0.0011	0.0307	CbGeAlD
Azathioprine—HPRT1—skin of body—skin cancer	0.0011	0.0307	CbGeAlD
Azathioprine—GSTM1—skin of body—skin cancer	0.00107	0.03	CbGeAlD
Azathioprine—HPRT1—mammalian vulva—skin cancer	0.001	0.028	CbGeAlD
Azathioprine—XDH—mammalian vulva—skin cancer	0.00099	0.0276	CbGeAlD
Azathioprine—GSTA1—head—skin cancer	0.000946	0.0264	CbGeAlD
Azathioprine—HPRT1—lymphoid tissue—skin cancer	0.00089	0.0248	CbGeAlD
Azathioprine—GSTM1—lymphoid tissue—skin cancer	0.000869	0.0243	CbGeAlD
Azathioprine—HPRT1—female reproductive system—skin cancer	0.000858	0.024	CbGeAlD
Azathioprine—XDH—female reproductive system—skin cancer	0.000848	0.0237	CbGeAlD
Azathioprine—GSTA2—lymphoid tissue—skin cancer	0.000847	0.0237	CbGeAlD
Azathioprine—TPMT—mammalian vulva—skin cancer	0.000845	0.0236	CbGeAlD
Azathioprine—GSTM1—female reproductive system—skin cancer	0.000838	0.0234	CbGeAlD
Azathioprine—GSTA2—female reproductive system—skin cancer	0.000817	0.0228	CbGeAlD
Azathioprine—HPRT1—head—skin cancer	0.000717	0.02	CbGeAlD
Azathioprine—GSTM1—head—skin cancer	0.0007	0.0195	CbGeAlD
Azathioprine—GSTA2—head—skin cancer	0.000683	0.0191	CbGeAlD
Azathioprine—TPMT—head—skin cancer	0.000605	0.0169	CbGeAlD
Azathioprine—Alopecia—Vismodegib—skin cancer	0.000567	0.00633	CcSEcCtD
Azathioprine—Hepatic function abnormal—Imiquimod—skin cancer	0.000559	0.00624	CcSEcCtD
Azathioprine—Interstitial pneumonia—Docetaxel—skin cancer	0.000555	0.0062	CcSEcCtD
Azathioprine—Herpes zoster—Temozolomide—skin cancer	0.000536	0.00598	CcSEcCtD
Azathioprine—Cholestasis—Temozolomide—skin cancer	0.000531	0.00593	CcSEcCtD
Azathioprine—Hepatotoxicity—Temozolomide—skin cancer	0.000522	0.00583	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.000516	0.00576	CcSEcCtD
Azathioprine—HPRT1—lymph node—skin cancer	0.000502	0.014	CbGeAlD
Azathioprine—Rigors—Temozolomide—skin cancer	0.000494	0.00552	CcSEcCtD
Azathioprine—GSTM1—lymph node—skin cancer	0.00049	0.0137	CbGeAlD
Azathioprine—Liver injury—Temozolomide—skin cancer	0.000479	0.00535	CcSEcCtD
Azathioprine—Arthralgia—Vismodegib—skin cancer	0.000475	0.00531	CcSEcCtD
Azathioprine—Myalgia—Vismodegib—skin cancer	0.000475	0.00531	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.000472	0.00527	CcSEcCtD
Azathioprine—Skin disorder—Vismodegib—skin cancer	0.000443	0.00494	CcSEcCtD
Azathioprine—Infestation NOS—Vemurafenib—skin cancer	0.000441	0.00493	CcSEcCtD
Azathioprine—Infestation—Vemurafenib—skin cancer	0.000441	0.00493	CcSEcCtD
Azathioprine—Polyp—Docetaxel—skin cancer	0.000441	0.00492	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.000438	0.00489	CcSEcCtD
Azathioprine—TPMT—lymph node—skin cancer	0.000423	0.0118	CbGeAlD
Azathioprine—Aplastic anaemia—Dactinomycin—skin cancer	0.000419	0.00468	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.000415	0.00464	CcSEcCtD
Azathioprine—Cyst—Docetaxel—skin cancer	0.000401	0.00448	CcSEcCtD
Azathioprine—Pancytopenia—Imiquimod—skin cancer	0.000401	0.00448	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Vismodegib—skin cancer	0.000393	0.00439	CcSEcCtD
Azathioprine—Interstitial lung disease—Docetaxel—skin cancer	0.000379	0.00423	CcSEcCtD
Azathioprine—Aplastic anaemia—Temozolomide—skin cancer	0.000379	0.00423	CcSEcCtD
Azathioprine—Infestation—Imiquimod—skin cancer	0.000376	0.00421	CcSEcCtD
Azathioprine—Infestation NOS—Imiquimod—skin cancer	0.000376	0.00421	CcSEcCtD
Azathioprine—Erythema multiforme—Vemurafenib—skin cancer	0.000375	0.00419	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.000373	0.00417	CcSEcCtD
Azathioprine—Gastrointestinal pain—Vismodegib—skin cancer	0.000373	0.00416	CcSEcCtD
Azathioprine—Neoplasm—Temozolomide—skin cancer	0.000365	0.00407	CcSEcCtD
Azathioprine—Abdominal pain—Vismodegib—skin cancer	0.00036	0.00402	CcSEcCtD
Azathioprine—Hepatic failure—Dactinomycin—skin cancer	0.00036	0.00402	CcSEcCtD
Azathioprine—Mediastinal disorder—Vemurafenib—skin cancer	0.000357	0.00399	CcSEcCtD
Azathioprine—Hepatobiliary disease—Imiquimod—skin cancer	0.000356	0.00398	CcSEcCtD
Azathioprine—Chills—Vemurafenib—skin cancer	0.000356	0.00397	CcSEcCtD
Azathioprine—Alopecia—Vemurafenib—skin cancer	0.00035	0.00391	CcSEcCtD
Azathioprine—Hepatotoxicity—Docetaxel—skin cancer	0.000347	0.00388	CcSEcCtD
Azathioprine—Haemoglobin—Imiquimod—skin cancer	0.00034	0.00379	CcSEcCtD
Azathioprine—Haemorrhage—Imiquimod—skin cancer	0.000338	0.00378	CcSEcCtD
Azathioprine—Rigors—Docetaxel—skin cancer	0.000328	0.00367	CcSEcCtD
Azathioprine—Hepatic failure—Temozolomide—skin cancer	0.000326	0.00364	CcSEcCtD
Azathioprine—Erythema multiforme—Imiquimod—skin cancer	0.00032	0.00357	CcSEcCtD
Azathioprine—Diarrhoea—Vismodegib—skin cancer	0.000312	0.00348	CcSEcCtD
Azathioprine—Immune system disorder—Imiquimod—skin cancer	0.000305	0.00341	CcSEcCtD
Azathioprine—Mediastinal disorder—Imiquimod—skin cancer	0.000305	0.0034	CcSEcCtD
Azathioprine—Chills—Imiquimod—skin cancer	0.000303	0.00339	CcSEcCtD
Azathioprine—Arrhythmia—Imiquimod—skin cancer	0.000302	0.00337	CcSEcCtD
Azathioprine—Alopecia—Imiquimod—skin cancer	0.000299	0.00334	CcSEcCtD
Azathioprine—Arthralgia—Vemurafenib—skin cancer	0.000294	0.00328	CcSEcCtD
Azathioprine—Myalgia—Vemurafenib—skin cancer	0.000294	0.00328	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000292	0.00326	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.000291	0.00326	CcSEcCtD
Azathioprine—Vomiting—Vismodegib—skin cancer	0.00029	0.00324	CcSEcCtD
Azathioprine—Rash—Vismodegib—skin cancer	0.000287	0.00321	CcSEcCtD
Azathioprine—Dermatitis—Vismodegib—skin cancer	0.000287	0.00321	CcSEcCtD
Azathioprine—Pancytopenia—Bleomycin—skin cancer	0.000285	0.00318	CcSEcCtD
Azathioprine—Infection—Vemurafenib—skin cancer	0.00028	0.00312	CcSEcCtD
Azathioprine—Skin disorder—Vemurafenib—skin cancer	0.000273	0.00305	CcSEcCtD
Azathioprine—Ill-defined disorder—Imiquimod—skin cancer	0.000273	0.00305	CcSEcCtD
Azathioprine—Nausea—Vismodegib—skin cancer	0.000271	0.00302	CcSEcCtD
Azathioprine—Pneumonia—Bleomycin—skin cancer	0.000269	0.003	CcSEcCtD
Azathioprine—Hepatocellular injury—Docetaxel—skin cancer	0.000268	0.003	CcSEcCtD
Azathioprine—Pancytopenia—Dactinomycin—skin cancer	0.000266	0.00297	CcSEcCtD
Azathioprine—Malaise—Imiquimod—skin cancer	0.000265	0.00296	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.000264	0.00294	CcSEcCtD
Azathioprine—Hypotension—Vemurafenib—skin cancer	0.000263	0.00294	CcSEcCtD
Azathioprine—Colitis—Docetaxel—skin cancer	0.000257	0.00288	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000256	0.00287	CcSEcCtD
Azathioprine—Pneumonia—Dactinomycin—skin cancer	0.000251	0.0028	CcSEcCtD
Azathioprine—Arthralgia—Imiquimod—skin cancer	0.00025	0.0028	CcSEcCtD
Azathioprine—Myalgia—Imiquimod—skin cancer	0.00025	0.0028	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000249	0.00278	CcSEcCtD
Azathioprine—Discomfort—Imiquimod—skin cancer	0.000247	0.00276	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000247	0.00276	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000243	0.00272	CcSEcCtD
Azathioprine—Neoplasm—Docetaxel—skin cancer	0.000242	0.00271	CcSEcCtD
Azathioprine—Haemoglobin—Bleomycin—skin cancer	0.000241	0.0027	CcSEcCtD
Azathioprine—Pancytopenia—Temozolomide—skin cancer	0.00024	0.00268	CcSEcCtD
Azathioprine—Haemorrhage—Bleomycin—skin cancer	0.00024	0.00268	CcSEcCtD
Azathioprine—Infection—Imiquimod—skin cancer	0.000239	0.00266	CcSEcCtD
Azathioprine—Skin disorder—Imiquimod—skin cancer	0.000233	0.00261	CcSEcCtD
Azathioprine—Agranulocytosis—Dactinomycin—skin cancer	0.000233	0.0026	CcSEcCtD
Azathioprine—Pneumonia—Temozolomide—skin cancer	0.000227	0.00253	CcSEcCtD
Azathioprine—Infestation NOS—Temozolomide—skin cancer	0.000226	0.00252	CcSEcCtD
Azathioprine—Infestation—Temozolomide—skin cancer	0.000226	0.00252	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000224	0.0025	CcSEcCtD
Azathioprine—Body temperature increased—Vemurafenib—skin cancer	0.000223	0.00249	CcSEcCtD
Azathioprine—Pancytopenia—Fluorouracil—skin cancer	0.000221	0.00247	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000219	0.00244	CcSEcCtD
Azathioprine—Hepatic failure—Docetaxel—skin cancer	0.000217	0.00242	CcSEcCtD
Azathioprine—Chills—Bleomycin—skin cancer	0.000215	0.00241	CcSEcCtD
Azathioprine—Hepatobiliary disease—Temozolomide—skin cancer	0.000213	0.00238	CcSEcCtD
Azathioprine—Alopecia—Bleomycin—skin cancer	0.000212	0.00237	CcSEcCtD
Azathioprine—Erythema multiforme—Dactinomycin—skin cancer	0.000212	0.00236	CcSEcCtD
Azathioprine—Pneumonia—Fluorouracil—skin cancer	0.000209	0.00234	CcSEcCtD
Azathioprine—Infestation NOS—Fluorouracil—skin cancer	0.000208	0.00232	CcSEcCtD
Azathioprine—Infestation—Fluorouracil—skin cancer	0.000208	0.00232	CcSEcCtD
Azathioprine—Hypersensitivity—Vemurafenib—skin cancer	0.000207	0.00232	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000207	0.00232	CcSEcCtD
Azathioprine—Haemoglobin—Temozolomide—skin cancer	0.000204	0.00227	CcSEcCtD
Azathioprine—Haemorrhage—Temozolomide—skin cancer	0.000203	0.00226	CcSEcCtD
Azathioprine—Chills—Dactinomycin—skin cancer	0.000201	0.00224	CcSEcCtD
Azathioprine—Alopecia—Dactinomycin—skin cancer	0.000198	0.00221	CcSEcCtD
Azathioprine—Feeling abnormal—Imiquimod—skin cancer	0.000198	0.00221	CcSEcCtD
Azathioprine—Gastrointestinal pain—Imiquimod—skin cancer	0.000196	0.00219	CcSEcCtD
Azathioprine—Agranulocytosis—Fluorouracil—skin cancer	0.000194	0.00217	CcSEcCtD
Azathioprine—Ill-defined disorder—Bleomycin—skin cancer	0.000194	0.00217	CcSEcCtD
Azathioprine—Anaemia—Bleomycin—skin cancer	0.000193	0.00216	CcSEcCtD
Azathioprine—Diarrhoea—Vemurafenib—skin cancer	0.000193	0.00215	CcSEcCtD
Azathioprine—Erythema multiforme—Temozolomide—skin cancer	0.000191	0.00214	CcSEcCtD
Azathioprine—Abdominal pain—Imiquimod—skin cancer	0.00019	0.00212	CcSEcCtD
Azathioprine—Body temperature increased—Imiquimod—skin cancer	0.00019	0.00212	CcSEcCtD
Azathioprine—Malaise—Bleomycin—skin cancer	0.000188	0.00211	CcSEcCtD
Azathioprine—Haemoglobin—Fluorouracil—skin cancer	0.000188	0.0021	CcSEcCtD
Azathioprine—Leukopenia—Bleomycin—skin cancer	0.000187	0.00209	CcSEcCtD
Azathioprine—Haemorrhage—Fluorouracil—skin cancer	0.000187	0.00208	CcSEcCtD
Azathioprine—Dizziness—Vemurafenib—skin cancer	0.000186	0.00208	CcSEcCtD
Azathioprine—Immune system disorder—Temozolomide—skin cancer	0.000183	0.00204	CcSEcCtD
Azathioprine—Mediastinal disorder—Temozolomide—skin cancer	0.000183	0.00204	CcSEcCtD
Azathioprine—Chills—Temozolomide—skin cancer	0.000182	0.00203	CcSEcCtD
Azathioprine—Ill-defined disorder—Dactinomycin—skin cancer	0.000181	0.00202	CcSEcCtD
Azathioprine—Anaemia—Dactinomycin—skin cancer	0.00018	0.00201	CcSEcCtD
Azathioprine—Vomiting—Vemurafenib—skin cancer	0.000179	0.002	CcSEcCtD
Azathioprine—Alopecia—Temozolomide—skin cancer	0.000179	0.002	CcSEcCtD
Azathioprine—Myalgia—Bleomycin—skin cancer	0.000178	0.00199	CcSEcCtD
Azathioprine—Rash—Vemurafenib—skin cancer	0.000178	0.00198	CcSEcCtD
Azathioprine—Dermatitis—Vemurafenib—skin cancer	0.000177	0.00198	CcSEcCtD
Azathioprine—Hypersensitivity—Imiquimod—skin cancer	0.000177	0.00198	CcSEcCtD
Azathioprine—Headache—Vemurafenib—skin cancer	0.000176	0.00197	CcSEcCtD
Azathioprine—Discomfort—Bleomycin—skin cancer	0.000176	0.00196	CcSEcCtD
Azathioprine—Malaise—Dactinomycin—skin cancer	0.000176	0.00196	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000175	0.00196	CcSEcCtD
Azathioprine—Leukopenia—Dactinomycin—skin cancer	0.000174	0.00195	CcSEcCtD
Azathioprine—Infection—Bleomycin—skin cancer	0.000169	0.00189	CcSEcCtD
Azathioprine—Nausea—Vemurafenib—skin cancer	0.000167	0.00187	CcSEcCtD
Azathioprine—Thrombocytopenia—Bleomycin—skin cancer	0.000167	0.00187	CcSEcCtD
Azathioprine—Arrhythmia—Fluorouracil—skin cancer	0.000167	0.00186	CcSEcCtD
Azathioprine—Myalgia—Dactinomycin—skin cancer	0.000166	0.00185	CcSEcCtD
Azathioprine—Alopecia—Fluorouracil—skin cancer	0.000165	0.00184	CcSEcCtD
Azathioprine—Diarrhoea—Imiquimod—skin cancer	0.000164	0.00184	CcSEcCtD
Azathioprine—Discomfort—Dactinomycin—skin cancer	0.000164	0.00183	CcSEcCtD
Azathioprine—Ill-defined disorder—Temozolomide—skin cancer	0.000164	0.00183	CcSEcCtD
Azathioprine—Anaemia—Temozolomide—skin cancer	0.000163	0.00182	CcSEcCtD
Azathioprine—Pancytopenia—Docetaxel—skin cancer	0.00016	0.00179	CcSEcCtD
Azathioprine—Hypotension—Bleomycin—skin cancer	0.000159	0.00178	CcSEcCtD
Azathioprine—Malaise—Temozolomide—skin cancer	0.000159	0.00178	CcSEcCtD
Azathioprine—Dizziness—Imiquimod—skin cancer	0.000159	0.00177	CcSEcCtD
Azathioprine—Infection—Dactinomycin—skin cancer	0.000158	0.00177	CcSEcCtD
Azathioprine—Leukopenia—Temozolomide—skin cancer	0.000158	0.00176	CcSEcCtD
Azathioprine—Thrombocytopenia—Dactinomycin—skin cancer	0.000156	0.00174	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000155	0.00174	CcSEcCtD
Azathioprine—Vomiting—Imiquimod—skin cancer	0.000153	0.00171	CcSEcCtD
Azathioprine—Rash—Imiquimod—skin cancer	0.000151	0.00169	CcSEcCtD
Azathioprine—Dermatitis—Imiquimod—skin cancer	0.000151	0.00169	CcSEcCtD
Azathioprine—Pneumonia—Docetaxel—skin cancer	0.000151	0.00169	CcSEcCtD
Azathioprine—Headache—Imiquimod—skin cancer	0.00015	0.00168	CcSEcCtD
Azathioprine—Anaemia—Fluorouracil—skin cancer	0.00015	0.00168	CcSEcCtD
Azathioprine—Myalgia—Temozolomide—skin cancer	0.00015	0.00168	CcSEcCtD
Azathioprine—Arthralgia—Temozolomide—skin cancer	0.00015	0.00168	CcSEcCtD
Azathioprine—Infestation NOS—Docetaxel—skin cancer	0.00015	0.00168	CcSEcCtD
Azathioprine—Infestation—Docetaxel—skin cancer	0.00015	0.00168	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000149	0.00167	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000149	0.00166	CcSEcCtD
Azathioprine—Discomfort—Temozolomide—skin cancer	0.000148	0.00166	CcSEcCtD
Azathioprine—Leukopenia—Fluorouracil—skin cancer	0.000145	0.00162	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000145	0.00162	CcSEcCtD
Azathioprine—Infection—Temozolomide—skin cancer	0.000143	0.0016	CcSEcCtD
Azathioprine—Nausea—Imiquimod—skin cancer	0.000143	0.00159	CcSEcCtD
Azathioprine—Hepatobiliary disease—Docetaxel—skin cancer	0.000142	0.00159	CcSEcCtD
Azathioprine—Thrombocytopenia—Temozolomide—skin cancer	0.000141	0.00157	CcSEcCtD
Azathioprine—Feeling abnormal—Bleomycin—skin cancer	0.000141	0.00157	CcSEcCtD
Azathioprine—Agranulocytosis—Docetaxel—skin cancer	0.00014	0.00156	CcSEcCtD
Azathioprine—Skin disorder—Temozolomide—skin cancer	0.00014	0.00156	CcSEcCtD
Azathioprine—Myalgia—Fluorouracil—skin cancer	0.000138	0.00154	CcSEcCtD
Azathioprine—Discomfort—Fluorouracil—skin cancer	0.000137	0.00153	CcSEcCtD
Azathioprine—Haemoglobin—Docetaxel—skin cancer	0.000135	0.00151	CcSEcCtD
Azathioprine—Body temperature increased—Bleomycin—skin cancer	0.000135	0.00151	CcSEcCtD
Azathioprine—Haemorrhage—Docetaxel—skin cancer	0.000135	0.0015	CcSEcCtD
Azathioprine—Infection—Fluorouracil—skin cancer	0.000132	0.00147	CcSEcCtD
Azathioprine—Feeling abnormal—Dactinomycin—skin cancer	0.000131	0.00146	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000131	0.00146	CcSEcCtD
Azathioprine—Gastrointestinal pain—Dactinomycin—skin cancer	0.00013	0.00145	CcSEcCtD
Azathioprine—Thrombocytopenia—Fluorouracil—skin cancer	0.00013	0.00145	CcSEcCtD
Azathioprine—Erythema multiforme—Docetaxel—skin cancer	0.000127	0.00142	CcSEcCtD
Azathioprine—Abdominal pain—Dactinomycin—skin cancer	0.000126	0.0014	CcSEcCtD
Azathioprine—Body temperature increased—Dactinomycin—skin cancer	0.000126	0.0014	CcSEcCtD
Azathioprine—Hypersensitivity—Bleomycin—skin cancer	0.000126	0.0014	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000124	0.00139	CcSEcCtD
Azathioprine—Hypotension—Fluorouracil—skin cancer	0.000124	0.00138	CcSEcCtD
Azathioprine—Immune system disorder—Docetaxel—skin cancer	0.000122	0.00136	CcSEcCtD
Azathioprine—Mediastinal disorder—Docetaxel—skin cancer	0.000121	0.00136	CcSEcCtD
Azathioprine—Chills—Docetaxel—skin cancer	0.000121	0.00135	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000121	0.00135	CcSEcCtD
Azathioprine—Arrhythmia—Docetaxel—skin cancer	0.00012	0.00134	CcSEcCtD
Azathioprine—Alopecia—Docetaxel—skin cancer	0.000119	0.00133	CcSEcCtD
Azathioprine—Feeling abnormal—Temozolomide—skin cancer	0.000119	0.00132	CcSEcCtD
Azathioprine—Gastrointestinal pain—Temozolomide—skin cancer	0.000118	0.00131	CcSEcCtD
Azathioprine—Hypersensitivity—Dactinomycin—skin cancer	0.000117	0.00131	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000114	0.00128	CcSEcCtD
Azathioprine—Body temperature increased—Temozolomide—skin cancer	0.000114	0.00127	CcSEcCtD
Azathioprine—Abdominal pain—Temozolomide—skin cancer	0.000114	0.00127	CcSEcCtD
Azathioprine—Feeling abnormal—Fluorouracil—skin cancer	0.000109	0.00122	CcSEcCtD
Azathioprine—Diarrhoea—Dactinomycin—skin cancer	0.000109	0.00122	CcSEcCtD
Azathioprine—Vomiting—Bleomycin—skin cancer	0.000108	0.00121	CcSEcCtD
Azathioprine—Anaemia—Docetaxel—skin cancer	0.000108	0.00121	CcSEcCtD
Azathioprine—Rash—Bleomycin—skin cancer	0.000108	0.0012	CcSEcCtD
Azathioprine—Dermatitis—Bleomycin—skin cancer	0.000107	0.0012	CcSEcCtD
Azathioprine—Hypersensitivity—Temozolomide—skin cancer	0.000106	0.00118	CcSEcCtD
Azathioprine—Leukopenia—Docetaxel—skin cancer	0.000105	0.00117	CcSEcCtD
Azathioprine—Body temperature increased—Fluorouracil—skin cancer	0.000105	0.00117	CcSEcCtD
Azathioprine—Nausea—Bleomycin—skin cancer	0.000101	0.00113	CcSEcCtD
Azathioprine—Vomiting—Dactinomycin—skin cancer	0.000101	0.00113	CcSEcCtD
Azathioprine—Rash—Dactinomycin—skin cancer	0.0001	0.00112	CcSEcCtD
Azathioprine—Myalgia—Docetaxel—skin cancer	9.98e-05	0.00112	CcSEcCtD
Azathioprine—Arthralgia—Docetaxel—skin cancer	9.98e-05	0.00112	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	9.91e-05	0.00111	CcSEcCtD
Azathioprine—Diarrhoea—Temozolomide—skin cancer	9.84e-05	0.0011	CcSEcCtD
Azathioprine—Hypersensitivity—Fluorouracil—skin cancer	9.77e-05	0.00109	CcSEcCtD
Azathioprine—Dizziness—Temozolomide—skin cancer	9.51e-05	0.00106	CcSEcCtD
Azathioprine—Infection—Docetaxel—skin cancer	9.51e-05	0.00106	CcSEcCtD
Azathioprine—Nausea—Dactinomycin—skin cancer	9.45e-05	0.00106	CcSEcCtD
Azathioprine—Thrombocytopenia—Docetaxel—skin cancer	9.37e-05	0.00105	CcSEcCtD
Azathioprine—Skin disorder—Docetaxel—skin cancer	9.29e-05	0.00104	CcSEcCtD
Azathioprine—Vomiting—Temozolomide—skin cancer	9.15e-05	0.00102	CcSEcCtD
Azathioprine—Rash—Temozolomide—skin cancer	9.07e-05	0.00101	CcSEcCtD
Azathioprine—Diarrhoea—Fluorouracil—skin cancer	9.07e-05	0.00101	CcSEcCtD
Azathioprine—Dermatitis—Temozolomide—skin cancer	9.06e-05	0.00101	CcSEcCtD
Azathioprine—Headache—Temozolomide—skin cancer	9.01e-05	0.00101	CcSEcCtD
Azathioprine—Hypotension—Docetaxel—skin cancer	8.94e-05	0.000999	CcSEcCtD
Azathioprine—Dizziness—Fluorouracil—skin cancer	8.77e-05	0.000979	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Docetaxel—skin cancer	8.72e-05	0.000974	CcSEcCtD
Azathioprine—Nausea—Temozolomide—skin cancer	8.55e-05	0.000955	CcSEcCtD
Azathioprine—Vomiting—Fluorouracil—skin cancer	8.43e-05	0.000942	CcSEcCtD
Azathioprine—Rash—Fluorouracil—skin cancer	8.36e-05	0.000934	CcSEcCtD
Azathioprine—Dermatitis—Fluorouracil—skin cancer	8.35e-05	0.000933	CcSEcCtD
Azathioprine—Headache—Fluorouracil—skin cancer	8.3e-05	0.000928	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Docetaxel—skin cancer	8.26e-05	0.000923	CcSEcCtD
Azathioprine—Feeling abnormal—Docetaxel—skin cancer	7.88e-05	0.000881	CcSEcCtD
Azathioprine—Nausea—Fluorouracil—skin cancer	7.87e-05	0.00088	CcSEcCtD
Azathioprine—Gastrointestinal pain—Docetaxel—skin cancer	7.82e-05	0.000874	CcSEcCtD
Azathioprine—Body temperature increased—Docetaxel—skin cancer	7.56e-05	0.000845	CcSEcCtD
Azathioprine—Abdominal pain—Docetaxel—skin cancer	7.56e-05	0.000845	CcSEcCtD
Azathioprine—Hypersensitivity—Docetaxel—skin cancer	7.05e-05	0.000788	CcSEcCtD
Azathioprine—Diarrhoea—Docetaxel—skin cancer	6.55e-05	0.000731	CcSEcCtD
Azathioprine—Dizziness—Docetaxel—skin cancer	6.33e-05	0.000707	CcSEcCtD
Azathioprine—Vomiting—Docetaxel—skin cancer	6.08e-05	0.00068	CcSEcCtD
Azathioprine—Rash—Docetaxel—skin cancer	6.03e-05	0.000674	CcSEcCtD
Azathioprine—Dermatitis—Docetaxel—skin cancer	6.03e-05	0.000673	CcSEcCtD
Azathioprine—Headache—Docetaxel—skin cancer	5.99e-05	0.00067	CcSEcCtD
Azathioprine—Nausea—Docetaxel—skin cancer	5.68e-05	0.000635	CcSEcCtD
